This study examines the abnormal returns of Chinese firms dual‐listed on the Chinese mainland (A‐share) and Hong Kong SAR (H‐share) stock markets. The results show that abnormal returns are more significant for the existing H‐share firms cross‐listing back as (H‐to‐A cross‐listings) than for those that are the other way around (A‐to‐H cross‐listings). Further, the A‐share market is more responsive to announcements, whereas the H‐share market is more responsive to actual listings. The analysis of the underlying mechanisms reveals that the abnormal returns of A‐to‐H cross‐listings are associated with improved information. In contrast, the abnormal returns of H‐to‐A cross‐listings are related to an increase in valuation. Significant abnormal returns for H‐to‐A cross‐listings are driven mainly by reduced systematic risks and are more pronounced in the post‐1997 period. Overall, these results suggest that investors generally respond positively to AH dual listings of Chinese firms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.